Virtus ETF Advisers’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,749
| Closed | -$505K | – | 406 |
|
|
2021
Q2 | $505K | Sell |
2,749
-1,260
| -31% | -$231K | 0.21% | 147 |
|
|
2021
Q1 | $613K | Buy |
4,009
+115
| +3% | +$17.6K | 0.26% | 121 |
|
|
2020
Q4 | $608K | Sell |
3,894
-1,453
| -27% | -$227K | 0.25% | 111 |
|
|
2020
Q3 | $612K | Buy |
5,347
+181
| +4% | +$20.7K | 0.32% | 113 |
|
|
2020
Q2 | $580K | Sell |
5,166
-478
| -8% | -$53.7K | 0.27% | 123 |
|
|
2020
Q1 | $507K | Sell |
5,644
-457
| -7% | -$41.1K | 0.21% | 169 |
|
|
2019
Q4 | $660K | Buy |
6,101
+38
| +0.6% | +$4.11K | 0.11% | 164 |
|
|
2019
Q3 | $594K | Sell |
6,063
-801
| -12% | -$78.5K | 0.12% | 173 |
|
|
2019
Q2 | $899K | Buy |
+6,864
| New | +$899K | 0.19% | 154 |
|
|
2016
Q4 | – | Sell |
-4,745
| Closed | -$581K | – | 199 |
|
|
2016
Q3 | $581K | Buy |
4,745
+598
| +14% | +$73.2K | 0.28% | 64 |
|
|
2016
Q2 | $484K | Buy |
4,147
+980
| +31% | +$114K | 0.36% | 61 |
|
|
2016
Q1 | $441K | Hold |
3,167
| – | – | 0.61% | 46 |
|
|
2015
Q4 | $604K | Buy |
+3,167
| New | +$604K | 1.66% | 15 |
|